CoChat

Caffeine Promotes Ultraviolet B-induced Apoptosis in Human Keratinocytes without Complete DNA Repair

Open access
Han, Weinong, Ming, Mei, He, Yu-Ying · 2011 · Journal of Biological Chemistry
Cited by 66

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

In response to ultraviolet B damage, keratinocytes undergo apoptosis to eliminate damaged cells, thereby preventing tumorigenic transformation. Caffeine, the most widely consumed psychoactive substance, produces complex pharmacological actions; it has been shown to be chemopreventive in non-melamona skin cancer in mice through increasing apoptosis. Here we have investigated the molecular and cellular mechanisms in the pro-apoptotic effect of caffeine on UVB-irradiated human HaCaT keratinocytes. Pretreatment with caffeine increased UVB-induced apoptosis in HaCaT cells. Caffeine blocked UVB-induced Chk1 phosphorylation. In addition, similar to the effect of the PI3K inhibitor LY294002, caffeine also inhibited phosphorylation of AKT and up-regulation of COX-2, two critical oncogenic pathways in skin tumorigenesis. However, phosphorylation of EGFR or ERK was unaffected. Inhibiting ATR pathways by siRNA targeting ATR had little effect on UVB-induced apoptosis or AKT activation, indicating that the inhibitory effect of caffeine on apoptosis and the AKT pathway does not require the ATR pathway. Inhibiting AKT by caffeine blocked UVB-induced COX-2 up-regulation. Expression of constitutively active AKT that was not inhibited by caffeine was found to protect cells from caffeine-promoted apoptosis post-UVB irradiation, indicating that AKT is an essential inhibitory target for caffeine to promote apoptosis. Caffeine specifically sensitized cells with unrepaired DNA damage to UVB-induced apoptosis. These findings indicate that in HaCaT keratinocytes, inhibiting the AKT/COX-2 pathways through an ATR-independent pathway is a critical molecular mechanism by which caffeine promotes UVB-induced apoptosis of unrepaired keratinocytes for elimination.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m111.222349

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 45

  1. Bowden, 2004, Nat. Rev. Cancer, 4, 23, 10.1038/nrc1253 · DOI · Paper page
  2. Johnson, 1998, J. Am. Acad. Dermatol., 38, 681, 10.1016/S0190-9622(98)70196-3 · DOI
  3. Niggli, 1988, J. Invest. Dermatol., 91, 579, 10.1111/1523-1747.ep12477095 · DOI
  4. Vink, 1991, Carcinogenesis, 12, 861, 10.1093/carcin/12.5.861 · DOI · Paper page
  5. Matsuoka, 1998, Science, 282, 1893, 10.1126/science.282.5395.1893 · DOI · Paper page
  6. Chaturvedi, 1999, Oncogene, 18, 4047, 10.1038/sj.onc.1202925 · DOI · Paper page
  7. Matsuoka, 2000, Proc. Natl. Acad. Sci. U.S.A., 97, 10389, 10.1073/pnas.190030497 · DOI · Paper page
  8. Ahn, 2000, Cancer Res., 60, 5934
  9. Menoyo, 2001, Cancer Res., 61, 7727
  10. Swift, 1987, New Engl. J. Med., 316, 1289, 10.1056/NEJM198705213162101 · DOI · Paper page
  11. Renwick, 2006, Nat. Genet., 38, 873, 10.1038/ng1837 · DOI · Paper page
  12. Hannan, 2002, Carcinogenesis, 23, 1617, 10.1093/carcin/23.10.1617 · DOI · Paper page
  13. Hirao, 2002, Mol. Cell. Biol., 22, 6521, 10.1128/MCB.22.18.6521-6532.2002 · DOI · Paper page
  14. Kandel, 1999, Exp. Cell Res., 253, 210, 10.1006/excr.1999.4690 · DOI · Paper page
  15. Lawlor, 2001, J. Cell Sci., 114, 2903, 10.1242/jcs.114.16.2903 · DOI · Paper page
  16. Datta, 1999, Genes Dev., 13, 2905, 10.1101/gad.13.22.2905 · DOI · Paper page
  17. Bode, 2003, Sci. STKE, 2003, RE2, 10.1126/stke.2003.167.re2 · DOI · Paper page
  18. Ming, 2010, Oncogene, 29, 492, 10.1038/onc.2009.357 · DOI · Paper page
  19. An, 2002, Photochem. Photobiol., 76, 73, 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2 · doi:10.1562/0031-8655(2002)076<0073:ceimah>2.0.co;2
  20. Fischer, 2007, Mol. Carcinog., 46, 363, 10.1002/mc.20284 · DOI · Paper page
  21. Pentland, 1999, Carcinogenesis, 20, 1939, 10.1093/carcin/20.10.1939 · DOI · Paper page
  22. Tiano, 2002, Cancer Res., 62, 3395
  23. Buckman, 1998, Carcinogenesis, 19, 723, 10.1093/carcin/19.5.723 · DOI · Paper page
  24. Lu, 2007, Carcinogenesis, 28, 199, 10.1093/carcin/bgl112 · DOI · Paper page
  25. Lu, 2008, Cancer Res., 68, 2523, 10.1158/0008-5472.CAN-07-5955 · DOI · Paper page
  26. de Gruijl, 2002, Exp. Dermatol., 11, 37, 10.1034/j.1600-0625.11.s.1.9.x · DOI
  27. Ling, 2001, Am. J. Pathol., 159, 1247, 10.1016/S0002-9440(10)62511-4 · DOI
  28. Nakazawa, 1994, Proc. Natl. Acad. Sci. U.S.A., 91, 360, 10.1073/pnas.91.1.360 · DOI · Paper page
  29. Han, 2010, J. Biol. Chem., 285, 11369, 10.1074/jbc.M109.028142 · DOI
  30. He, 2006, Oncogene, 25, 3680, 10.1038/sj.onc.1209384 · DOI
  31. Ming, 2010, Proc. Natl. Acad. Sci. U.S.A., 107, 22623, 10.1073/pnas.1010377108 · DOI · Paper page
  32. Nakagawa, 1998, J. Invest. Dermatol., 110, 143, 10.1046/j.1523-1747.1998.00100.x · DOI
  33. Chun, 2007, Cancer Res., 67, 2015, 10.1158/0008-5472.CAN-06-3617 · DOI · Paper page
  34. Nghiem, 2002, J. Biol. Chem., 277, 4428, 10.1074/jbc.M106113200 · DOI · Paper page
  35. He, 2003, Cancer Res., 63, 4396
  36. Lu, 2004, Cancer Res., 64, 5020, 10.1158/0008-5472.CAN-04-0760 · DOI · Paper page
  37. Tang, 2001, Cancer Res., 61, 4329
  38. Hashimoto, 2004, Cancer Res., 64, 3344, 10.1158/0008-5472.CAN-03-3453 · DOI · Paper page
  39. Nomura, 2005, Mol. Carcinog., 44, 67, 10.1002/mc.20120 · DOI
  40. Sinn, 2010, Mol. Cancer Ther., 9, 480, 10.1158/1535-7163.MCT-09-0498 · DOI
  41. Fiebich, 2000, Neuropharmacology, 39, 2205, 10.1016/S0028-3908(00)00045-9 · DOI
  42. Foukas, 2002, J. Biol. Chem., 277, 37124, 10.1074/jbc.M202101200 · DOI · Paper page
  43. Auclair, 2008, Proc. Natl. Acad. Sci. U.S.A., 105, 17896, 10.1073/pnas.0801585105 · DOI · Paper page
  44. Selby, 1990, Proc. Natl. Acad. Sci. U.S.A., 87, 3522, 10.1073/pnas.87.9.3522 · DOI
  45. Cortez, 2003, J. Biol. Chem., 278, 37139, 10.1074/jbc.M307088200 · DOI · Paper page

Cited by

Metadata

Authors
Han, W., Ming, M., & He, Y.-Y.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2011-07
Volume
286
Issue
26
Pages
22825-22832
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2030430546
Cited by
66
References
14
FWCI
9.24
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.